Tune in to learn more about the results from PEARL: AgelessRx 12 month decentralized clinical trial in generally healthy individuals taking Rapamycin for longevity.
🧬 Longevity & Aging Series (S3, E6): Girish Harinath from AgelessRx joins host Dr. Evgeniy Galimov to discuss a #research paper he co-authored in Volume 17, Issue 4, titled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.” 🎥 https://lnkd.in/esYAQaRB #author #interview #authorinterview #aging #rapamycin #geroscience #longevity #series #healthspan #openaccess #openscience #peerreviewed #journal #publishing #meded
